Tag: stays
ASCO: Roche’s Alecensa stays on top of Xalkori with long-term survival...
Roche made a splash at ASCO three years ago with data showing that its Alecensa could top Pfizer’s Xalkori at keeping ALK-positive lung-cancer at bay....
